Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5953
    +0.0016 (+0.27%)
     
  • NZD/EUR

    0.5553
    +0.0007 (+0.13%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    83.06
    +0.25 (+0.30%)
     
  • GOLD

    2,333.70
    -4.70 (-0.20%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    0.00 (0.00%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,298.34
    +97.07 (+0.56%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.6170
    +0.5020 (+0.54%)
     

Analysts’ Views on Colgate-Palmolive, Post-1Q18 Results

Analysts’ Views on Colgate-Palmolive, Post-1Q18 Results

Numerous analysts covering Colgate-Palmolive (CL) stock decreased their target prices after the company’s 1Q18 results. Jefferies dropped its price target to $67 per share from $77, Wells Fargo reduced it to $68 from $73, and Berenberg lowered its target price to $67 from $69. The graph below shows the decline in analysts’ target prices for Colgate-Palmolive stock.